COVID-19 is associated with significant drops in CD4 count
27 March 2020. Related: COVID-19: pathogenesis, COVID-19.
2020
CoV-2 viral load in throat saliva samples correlates with clinical outcomes from COVID-19
27 March 2020. Related: COVID-19: pathogenesis, COVID-19.
Rapid and point of care testing for SARS-CoV-2
27 March 2020. Related: COVID-19: transmission & prevention, COVID-19.
Ongoing and planned studies for COVID-19
27 March 2020. Related: COVID-19: research studies, COVID-19.
NEAT ID develop COVID-19 and HIV coinfection data dashboard
27 March 2020. Related: COVID-19: research studies, COVID-19.
Open access publications on COVID-19 include Lancet, Nature, NEJM, JAMA, JID, CID and others
27 March 2020. Related: COVID-19: research studies, COVID-19: on the web, COVID-19.
Open access publishing on US PubMed Central
27 March 2020. Related: COVID-19: research studies, COVID-19: on the web, COVID-19.
Selected articles by UCSF: download 60 papers
27 March 2020. Related: COVID-19: research studies, COVID-19: on the web, COVID-19.
Peer-review articles on COVID-19 and pregnancy
27 March 2020. Related: COVID-19: transmission & prevention, COVID-19: on the web, COVID-19.
Drug-drug interactions and COVID-19
27 March 2020. Related: PK and drug interactions, COVID-19: other news, COVID-19: on the web, COVID-19.
Sex, HIV and STIs during COVID-19 pandemic
27 March 2020. Related: COVID-19: transmission & prevention, COVID-19: on the web, COVID-19.
Online information for people living with HIV
27 March 2020. Related: COVID-19: on the web, COVID-19.
Online talks about COVID-19
27 March 2020. Related: COVID-19: on the web, COVID-19.
27 March 2020 vol 21 no 4
27 March 2020. Related: PDFs.
HTB 12 March 2020 now online
12 March 2020. Related: Editorial.
HTB survey 2020 – please help with feedback
12 March 2020. Related: Editorial.
Fit for purpose: antiretroviral treatment optimisation March 2020
12 March 2020. Related: Special reports, Supplements, Fit for purpose, Antiretrovirals.
HIV pipeline 2020: new drugs in development – March 2020
12 March 2020. Related: Special reports, Pipeline report.
Conference on Retroviruses and Opportunistic Infections (CROI 2020)
12 March 2020. Related: Conference reports.
CROI 2020: Special session on COVID-19
12 March 2020. Related: Conference reports, Virology, COVID-19: pathogenesis, COVID-19: on the web.
Monthly islatravir for PEP and PrEP: 12 pills a year could cover unmet need for HIV prevention in billions of people globally
12 March 2020. Related: Conference reports, HIV prevention and transmission.
Long-acting cabotegravir and rilpivirine injections support two-monthly dosing
12 March 2020. Related: Conference reports, Antiretrovirals.
Safety and PK of bNAb elipovimab (GS-9722) support two-weekly dosing
12 March 2020. Related: Conference reports, Antiretrovirals.
First results with long-acting capsid inhibitor GS-6207: oral and subcutaneous formulations for use in naïve and multidrug resistance
12 March 2020. Related: Conference reports, Antiretrovirals.
Predicted diabetes risk with first-line ART regimens: results from the ADVANCE trial
12 March 2020. Related: Conference reports, Side effects.
Postpartum weight gain is higher with dolutegravir- compared with efavirenz-based ART among African women
12 March 2020. Related: Conference reports, Pregnancy, Side effects.
London patient is second person to be cured of HIV from allogeneic stem-cell transplant
12 March 2020. Related: Conference reports, Cure-related research.
The London Patient tells his story as second person cured of HIV
12 March 2020. Related: Conference reports, Cure-related research.
Dolutegravir/lamivudine FDC recommended by NHS England
12 March 2020. Related: Treatment access.
12 March 2020 vol 21 no 3
12 March 2020. Related: PDFs.
HTB 24 February 2020 online
24 February 2020. Related: Editorial.
17th European AIDS Conference (EACS 2019)
24 February 2020. Related: Conference reports.
Long-acting cabotegravir and rilpivirine: similar results in women and men
24 February 2020. Related: Conference reports, Antiretrovirals, Women's health.
Antiretroviral pregnancy registry: dolutegravir update
24 February 2020. Related: Conference reports, Pregnancy.
Bictegravir/emtricitabine/tenofovir alafenamide appears to be safe and effective in women: results from a pooled analysis
24 February 2020. Related: Conference reports, Pregnancy.
No HIV transmission among Swiss infants born to mothers with undetectable viral load and who did not receive neonatal PEP
24 February 2020. Related: Conference reports, HIV prevention and transmission.
Mediterranean diet associated with maintaining bacterial diversity and markers of reduced frailty in older HIV negative study
24 February 2020. Related: Coinfections and complications, Nutrition, Ageing and life expectancy.
HIV in the UK – 2019 reports and data
24 February 2020. Related: HIV prevention and transmission, On the web.
Leave no one behind: A manifesto for hepatitis C elimination
24 February 2020. Related: Hepatitis coinfection, On the web.
24 February 2020 vol 21 no 2
24 February 2020. Related: PDFs.
Large phase 3 HIV vaccine study in south Africa is stopped early due to lack of efficacy
21 February 2020. Related: HIV prevention and transmission, Vaccines and microbicides.
HTB 29 January 2020 online
29 January 2020. Related: Editorial.
i-Base guide to HIV testing and sexual transmission (January 2020)
29 January 2020. Related: Supplements, HIV prevention and transmission.
FDA decision on long-acting cabotegravir/rilpivirine (Cabenuva, Vocabria) injections delayed due to scale-up manufacturing problems
29 January 2020. Related: Antiretrovirals.
Fostemsavir submitted to EMA for treating multidrug resistant HIV
29 January 2020. Related: Antiretrovirals.
Gilead announces licensing agreement for Rockefeller University bNAbs
29 January 2020. Related: Antiretrovirals.
US HIV Guidelines updated (December 2019)
29 January 2020. Related: Guidelines.
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
29 January 2020. Related: Vaccines and microbicides.
29 January 2020 vol 21 no 1
29 January 2020. Related: PDFs.
BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved
28 January 2020. Related: Guidelines.
Updates to Liverpool University drug interactions website
7 January 2020. Related: PK and drug interactions.